US SB2074 | 2019-2020 | 116th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on July 10 2019 - 25% progression, died in committee
Action: 2019-07-10 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]

Summary

A bill to amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V, such as buprenorphine, for maintenance or detoxification treatment, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Mainstreaming Addiction Treatment Act of 2019

Sponsors


History

DateChamberAction
2019-07-10SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Same As/Similar To

HB2482 (Related) 2019-05-31 - Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Subjects


US Congress State Sources


Bill Comments

feedback